AzTrials
AzTrials

Intraocular Pressure DisorderNCT01737645

A Comparison of Intraocular Pressures (IOP) During Prolonged Trendelenburg Positioning in Morbidly Obese and Thin Patients

An observational study of Intraocular Pressure Disorder, run by Corewell Health East at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This study is to determine if there is a rise in eye pressure, when patients are placed in a position where the head is lower than the rest of the body during long surgeries. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Intraocular Pressure Disorder
How many people
4 participants
Where
1 siteUnited States
Study dates
Aug 2012to Jul 2014
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult Subjects undergoing prolonged procedures expected to be in steep Trendelenburg position. Procedure must be scheduled for > 3 hours, eg. robotic prostatectomy, hysterectomy, and cystectomy.

Who may be able to join

  • Subjects undergoing prolonged procedures (scheduled >3hr) in steep Trendelenburg position (eg. robotic prostatectomy, hysterectomy, cystectomy)
  • Morbidly obese subjects: BMI ≥ 35 kg/m2
  • Thin subjects: BMI ≤ 30 kg/m2
  • Age 18-70
  • ASA (American Society of Anesthesiologists) physical status classification I, II, or III

Who cannot join

  • Known history of glaucoma
  • Note:if initial IOP is noted to be >21mmHg (millimeters of mercury), patient will be excluded from study and an ophthalmology consultation will be obtained.Surgery will not be postponed.
  • Recent use of IOP lowering topical ophthalmic agents
  • Allergy to latex or proparacaine hydrochloride ophthalmic solution
  • Patients with active corneal epithelial defects or history of recurrent corneal erosion
  • Patients with underlying disorders that can directly increase intraocular pressure (thyroid eye disease, intra orbital tumors, orbital vascular malformation, Sturge-Weber disease, carotid or dural cavernous arteriovenous malformation, cavernous sinus pathology)
Show all 10Show fewer
  • History of corneal surgery, to include LASIK (laser-assisted in-situ keratomileusis)
  • Any eye surgery within prior 1 month
  • Known pregnancy
  • Cognitive impairment

Trial locations and contacts

1 site in 1 country.

United States1 site
  • William Beaumont Hospital

    Royal Oak, Michigan, 48073

Other trials in United States

About this study

This study is to determine if there is a rise in eye pressure, when patients are placed in a position where the head is lower than the rest of the body during long surgeries.

Read the detailed description

Eye pressure will be measured at protocol specified intervals.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01737645
Study groupRoleWhat they receive
obese patientsBMI (body mass index) more than or equal to 35 kg/m2 (weight in kilograms divided by the square of the height in metres)
Thin patientsBMI less than or equal to 30 kg/m2

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To compare the percent change from baseline IOP reading to the peak IOP reading during steep Trendelenburg positioning in thin subjects vs morbidly obese subjects.

    Measured: Measured from baseline IOP to peak IOP during steep Trendelenburg. The overall time frame for which the outcome measure is assessed is up to 3 years.

Secondary outcomes (2)
  1. To determine rate of rise of IOP during steep Trendelenburg positioning

    Measured: The time during the surgery when the patient is in steep Trendelenburg positioning. The overall time frame for which the outcome measure is assessed is up to 3 years.

  2. To compare peak IOP and rise of IOP during steep Trendelenburg positioning in thin vs morbidly obese subjects.

    Measured: The time during the surgery when the patient is in steep Trendelenburg positioning. The overall time frame for which the outcome measure is assessed is up to 3 years.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Nov 2012 (estimated)
  2. Study startAug 2012
  3. Primary completionJul 2014
  4. Study completionJul 2014

Why it stopped: Difficulty in enrolling subjects.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
4 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01737645
Sponsor's protocol ID
2011-273
Status last verified
Jul 2014
First submitted
16 Mar 2012
Last updated
17 Jul 2014
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Intraocular Pressure Disorder, run by Corewell Health East at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 17 Jul 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Difficulty in enrolling subjects.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To compare the percent change from baseline IOP reading to the peak IOP reading during steep Trendelenburg positioning in thin subjects vs morbidly obese subjects. (time frame: Measured from baseline IOP to peak IOP during steep Trendelenburg. The overall time frame for which the outcome measure is assessed is up to 3 years.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in